Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Meghan Jude Mooradian, M.D.

Concepts (202)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma15202457061.580 Why?
Proto-Oncogene Proteins B-raf6202420591.220 Why?
Carcinoma, Non-Small-Cell Lung16202454321.140 Why?
Lung Neoplasms222024135861.080 Why?
Colitis4202112420.660 Why?
Cryosurgery120244790.650 Why?
Mucositis120201080.640 Why?
Polymyalgia Rheumatica12018520.610 Why?
Protein Kinase Inhibitors6202457030.590 Why?
Celiac Disease220228200.550 Why?
Arthritis, Psoriatic120182190.500 Why?
Combined Modality Therapy9202485420.450 Why?
Immunomodulation120175490.430 Why?
Molecular Targeted Therapy4202428300.430 Why?
Antibodies, Monoclonal5202492630.380 Why?
Mitogen-Activated Protein Kinase Kinases220246370.360 Why?
Glucocorticoids1202021670.350 Why?
Tumor Microenvironment8202439480.340 Why?
Neoplasms102024223710.340 Why?
Receptor Protein-Tyrosine Kinases1201716270.330 Why?
Skin Neoplasms8202458630.330 Why?
Oximes220233030.330 Why?
Immunotherapy8202347550.320 Why?
Adenocarcinoma4202163950.310 Why?
Pyrimidinones220233860.310 Why?
Immunosuppressive Agents2202042060.300 Why?
Lymphohistiocytosis, Hemophagocytic220152710.290 Why?
Hospitalization32024108400.260 Why?
Pyridones220238190.250 Why?
Lymphocytes, Tumor-Infiltrating3202111050.240 Why?
Neoplasm Metastasis4202449120.240 Why?
Aged2620241715040.220 Why?
Humans6220247681660.220 Why?
Colorectal Neoplasms1202369740.210 Why?
Arthritis, Rheumatoid1201837810.210 Why?
Oncolytic Virotherapy220195200.200 Why?
Retrospective Studies222024817620.200 Why?
Aged, 80 and over122024596290.190 Why?
Thyroiditis12021860.180 Why?
Duodenitis12020200.180 Why?
Biopsy4202067930.170 Why?
Xeroderma Pigmentosum12019310.170 Why?
Middle Aged2420242234920.170 Why?
Phospholipase D12019700.170 Why?
Enterocolitis120201060.160 Why?
Male2920243647190.160 Why?
Exanthema120245030.160 Why?
Genes, cdc120191130.160 Why?
OX40 Ligand12019570.160 Why?
Hepatitis120212270.160 Why?
Antineoplastic Combined Chemotherapy Protocols72023118780.160 Why?
Acute Kidney Injury2202219420.150 Why?
Disease Progression52024136710.150 Why?
International Classification of Diseases120249370.150 Why?
Ablation Techniques120212550.150 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase120181170.150 Why?
Adjuvants, Immunologic120239980.150 Why?
Neoplasm Staging52024112440.150 Why?
Clinical Trials as Topic4201980540.140 Why?
Budgets120192320.140 Why?
Drug Resistance, Neoplasm3202453410.140 Why?
Female2820243971920.140 Why?
Patient Simulation120192970.140 Why?
Radiosurgery1201613300.140 Why?
Idiopathic Pulmonary Fibrosis120225210.130 Why?
Drug Eruptions120193350.130 Why?
Neurotoxicity Syndromes120203020.130 Why?
Toll-Like Receptors120195820.120 Why?
Carcinoma, Squamous Cell2202140580.120 Why?
Tissue Array Analysis120165510.120 Why?
Treatment Outcome112024653710.120 Why?
Adult1620242236460.120 Why?
Radiation-Sensitizing Agents120163480.120 Why?
Tumor Escape120173720.120 Why?
Mitogen-Activated Protein Kinases1201912450.110 Why?
Drug Resistance1202015990.110 Why?
Radiotherapy, Adjuvant1201917910.110 Why?
Abdominal Pain1202010700.110 Why?
Lung Diseases, Interstitial120229400.110 Why?
Psoriasis120219260.110 Why?
Peripheral Nervous System Diseases120197160.110 Why?
Diarrhea1202013200.110 Why?
Practice Guidelines as Topic2202174540.110 Why?
Brachytherapy1202112200.110 Why?
Prognosis72022300100.110 Why?
Mutation52024302380.100 Why?
Imidazoles1201811690.100 Why?
Skin Diseases1202110850.100 Why?
Intestinal Mucosa2202030440.100 Why?
Colon1202018010.100 Why?
Cross Infection1202114260.100 Why?
Immune System120177990.100 Why?
Colonoscopy1202014090.100 Why?
Myocarditis120198020.100 Why?
Ultrasonography1202460040.090 Why?
Antigens, CD1202140350.090 Why?
Embolization, Therapeutic1202114020.090 Why?
Drug Costs1201911950.090 Why?
Nervous System Diseases1202116620.090 Why?
Pneumonia1202221630.090 Why?
Cell Communication1201716600.090 Why?
Quinazolines1201613730.080 Why?
Cohort Studies52024417540.080 Why?
Tomography, X-Ray Computed42021207600.080 Why?
Cancer Vaccines1201710410.080 Why?
Proteomics1202339120.080 Why?
Oncogene Proteins, Fusion1201716130.080 Why?
Angiogenesis Inhibitors1201920560.080 Why?
Immunotherapy, Adoptive1201915120.080 Why?
Disease Management1201925360.080 Why?
Medical Oncology1202023460.080 Why?
Antineoplastic Agents22024136760.080 Why?
Neoplasm Recurrence, Local2202394190.070 Why?
Skin1202145030.070 Why?
Myocardium1201947880.070 Why?
Models, Economic220197190.060 Why?
Australia2201812650.060 Why?
Pain1201951000.060 Why?
Radioimmunotherapy12024930.060 Why?
Cytokines1201974530.060 Why?
DNA1201772140.050 Why?
Synovitis120242170.050 Why?
Disease-Free Survival3201868470.050 Why?
Nitric Oxide Synthase Type II120245140.050 Why?
Taxoids120166670.050 Why?
Consensus2202432120.050 Why?
Immunohistochemistry12016110950.050 Why?
Musculoskeletal System120241880.050 Why?
Prospective Studies42022549260.050 Why?
Cost-Benefit Analysis3201955360.050 Why?
Phenotype12019167260.050 Why?
Time Factors52021402180.040 Why?
Survival Analysis32018101010.040 Why?
Oncogenes1201612340.040 Why?
Surge Capacity12020490.040 Why?
Young Adult42020600660.040 Why?
Drug Administration Schedule2201948600.040 Why?
Clinical Trials, Phase III as Topic120248790.040 Why?
Genes, Tumor Suppressor1202410620.040 Why?
Censuses120211980.040 Why?
Microvilli120202350.040 Why?
Patient Care Team2202125230.040 Why?
Inpatients2202125660.040 Why?
Arthritis120246840.040 Why?
Tomography120214420.040 Why?
Incidence32022215380.040 Why?
Polyneuropathies120191390.040 Why?
Randomized Controlled Trials as Topic12015103990.040 Why?
Quality of Life32023134900.040 Why?
United States62020730390.030 Why?
MAP Kinase Kinase Kinases120182520.030 Why?
Carboplatin120197970.030 Why?
Point-of-Care Systems1202412380.030 Why?
Natural Language Processing1202412030.030 Why?
Markov Chains120199790.030 Why?
Fibrosis1202220800.030 Why?
SEER Program1202014440.030 Why?
Fatal Outcome1201918360.030 Why?
Diagnosis, Differential22020130140.030 Why?
Survival Rate22019128400.030 Why?
Tumor Suppressor Proteins1202428100.030 Why?
Proton Pump Inhibitors120195520.030 Why?
Intestine, Small1202012170.030 Why?
Creatinine1201919180.030 Why?
Physician's Role120209250.030 Why?
Radiography, Thoracic1201913210.030 Why?
Recurrence1201585090.030 Why?
Risk Factors42021749440.030 Why?
Chest Pain1201911010.030 Why?
Lung22022100990.030 Why?
Quality-Adjusted Life Years1201917410.020 Why?
Paclitaxel1201917330.020 Why?
Dyspnea1201913520.020 Why?
Immune Tolerance1202023230.020 Why?
Europe1201834360.020 Why?
Glomerular Filtration Rate1201922270.020 Why?
Adrenal Cortex Hormones1201918860.020 Why?
Animals220241692460.020 Why?
Signal Transduction22018236450.020 Why?
Risk Assessment22021243150.020 Why?
Mortality1202029110.020 Why?
Decision Support Techniques1201920080.020 Why?
Age Factors12015184120.020 Why?
Massachusetts1202188900.020 Why?
CD8-Positive T-Lymphocytes1202146480.020 Why?
Kaplan-Meier Estimate1201865260.020 Why?
T-Lymphocytes12024102660.020 Why?
Electronic Health Records1202448870.020 Why?
Sex Factors12020106320.020 Why?
Electrocardiography1201964120.020 Why?
Apoptosis1201995230.010 Why?
Autoimmune Diseases1201522570.010 Why?
Proportional Hazards Models12018125430.010 Why?
Registries1201983750.010 Why?
Pilot Projects1201687410.010 Why?
Predictive Value of Tests12019154540.010 Why?
Severity of Illness Index12019159480.010 Why?
Pandemics1202187480.010 Why?
Infant, Newborn12021264220.010 Why?
Adolescent22019891690.010 Why?
Mice12024820290.010 Why?
Follow-Up Studies12015393480.010 Why?
Mooradian's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (202)
Explore
_
Co-Authors (144)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.